Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HCA Healthcare, Inc.HCA · Entity 2929 | SVP & Chief Ethics Officer | November 14, 2024 | November 18, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HCA Healthcare, Inc.
Report date November 14, 2024 · Filed November 18, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,454 |
Reported balance
After 2024-11-14 transaction · row 1
1 source rowRow 1 · 2024-11-14 · Sale · Disposed 1,474 · Balance 9,454 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2021 Filed Feb 22, 2021 20:47 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 6,091 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013011 · doc4.xml · nonDerivative · entry 2 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,338 F2 · kind: On October 31, 2018, the reporting person was granted 3,740 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2018-2020. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2018-2020 earnings per share, the number of performance share units that vested equaled 162.88% of the units granted. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:47 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 2,231 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013011 · doc4.xml · nonDerivative · entry 1 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,247 F1 · kind: On January 31, 2018, the reporting person was granted 1,370 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2018-2020. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2018-2020 earnings per share, the number of performance share units that vested equaled 162.88% of the units granted. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:32 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 1,400 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-21-008356 · doc4.xml · derivative · entry 6 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700 Underlying: Common Stock · 1,400 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:32 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 653 | $179.30 | $117,082.90 |
DisclosureSEC source: 0001209191-21-008356 · doc4.xml · nonDerivative · entry 4 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,016 Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:32 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 1,400 | $47.97 | $67,158.00 |
DisclosureSEC source: 0001209191-21-008356 · doc4.xml · nonDerivative · entry 3 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:32 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 415 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008356 · doc4.xml · nonDerivative · entry 2 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,269 Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:32 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 280 | $177.11 | $49,590.80 |
DisclosureSEC source: 0001209191-21-008356 · doc4.xml · nonDerivative · entry 1 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,684 Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:32 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 6,280 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-21-008356 · doc4.xml · derivative · entry 5 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,280 Underlying: Common Stock · 6,280 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
| October 29, 2020 Filed Nov 2, 2020 19:59 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 1,268 | $124.41 | $157,747.32 |
DisclosureSEC source: 0001209191-20-056466 · doc4.xml · nonDerivative · entry 1 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,964 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.40 to $124.42, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:15 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 452 | $150.08 | $67,836.16 |
DisclosureSEC source: 0001209191-20-011780 · doc4.xml · nonDerivative · entry 2 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,232 Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:15 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 1,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011780 · doc4.xml · nonDerivative · entry 1 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,684 F1 · kind: On February 1, 2017, the reporting person was granted 1,460 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2017-2019. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2017-2019 earnings per share, the number of performance share units that vested equaled 117.86% of the units granted. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 17:53 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 1,956 | $146.46 | $286,474.59 |
DisclosureSEC source: 0001209191-20-008415 · doc4.xml · nonDerivative · entry 1 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,964 Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:48 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 8,280 | $0.00 Strike: $145.24 | $0.00 |
DisclosureSEC source: 0001209191-20-005896 · doc4.xml · derivative · entry 1 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,280 Underlying: Common Stock · 8,280 shares Expires 2030-01-29 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 17:36 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 2,540 | $135.21 | $343,438.48 |
DisclosureSEC source: 0001209191-19-055545 · doc4.xml · nonDerivative · entry 1 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,920 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.21 to $135.215, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 13, 2019 Filed Aug 15, 2019 16:40 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 2,250 | $0.00 Strike: $45.30 | $0.00 |
DisclosureSEC source: 0001209191-19-046152 · doc4.xml · derivative · entry 5 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,250 shares Expires 2023-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| August 13, 2019 Filed Aug 15, 2019 16:40 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 1,750 | $0.00 Strike: $45.30 | $0.00 |
DisclosureSEC source: 0001209191-19-046152 · doc4.xml · derivative · entry 4 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,750 shares Expires 2023-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal installments beginning on November 6, 2014. Read SEC document |
| August 13, 2019 Filed Aug 15, 2019 16:40 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 977 | $127.56 | $124,626.22 |
DisclosureSEC source: 0001209191-19-046152 · doc4.xml · nonDerivative · entry 3 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,460 Read SEC document |
| August 13, 2019 Filed Aug 15, 2019 16:40 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 2,047 | $127.90 | $261,811.30 |
DisclosureSEC source: 0001209191-19-046152 · doc4.xml · nonDerivative · entry 2 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,437 Read SEC document |
| August 13, 2019 Filed Aug 15, 2019 16:40 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 4,000 | $45.30 | $181,200.00 |
DisclosureSEC source: 0001209191-19-046152 · doc4.xml · nonDerivative · entry 1 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,484 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:32 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 446 | $142.01 | $63,336.46 |
DisclosureSEC source: 0001209191-19-013249 · doc4.xml · nonDerivative · entry 2 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,484 Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:32 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 1,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-013249 · doc4.xml · nonDerivative · entry 1 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,930 F1 · kind: On January 29, 2016, the reporting person was granted 1,390 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2016-2018. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2016-2018 earnings per share, the number of performance share units that vested equaled 122.25% of the units granted. Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 16:52 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 200 | $139.48 | $27,896.00 |
DisclosureSEC source: 0001209191-19-008594 · doc4.xml · nonDerivative · entry 2 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,231 Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 16:52 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 440 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-008594 · doc4.xml · nonDerivative · entry 1 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,431 Read SEC document |
| January 30, 2019 Filed Feb 1, 2019 18:11 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 8,000 | $0.00 Strike: $139.06 | $0.00 |
DisclosureSEC source: 0001209191-19-006598 · doc4.xml · derivative · entry 1 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2029-01-30 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 30, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.